Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households

Respiratory syncytial virus is the leading cause of lower respiratory tract infection among infants. RSV is a priority for vaccine development. In this study, we investigate the potential effectiveness of a two-vaccine strategy aimed at mothers-to-be, thereby boosting maternally acquired antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Brand, Samuel PC, Munywoki, Patrick, Walumbe, David, Keeling, Matthew J, Nokes, David James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556875/
https://www.ncbi.nlm.nih.gov/pubmed/32216871
http://dx.doi.org/10.7554/eLife.47003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556875/
https://www.ncbi.nlm.nih.gov/pubmed/32216871
http://dx.doi.org/10.7554/eLife.47003

Ejemplares similares